An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees
Clinical trial NCT00686582 · COMPLETED
Trial details
- NCT number
- NCT00686582
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2008-12-01
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.